524632
SHUKRAPHAR
Start SIP
Invest Now
Start SIP in SHUKRAPHAR
Shukra Pharmaceuticals live price: ₹39.69. It opened at ₹40 vs previous close ₹40; intraday high/low: ₹41/₹39. The 50 & 200 DMA stand at ₹42.67/₹35.71.
Shukra Pharmaceuticals Performance
- Low
- ₹39
- High
- ₹41
- 52 Week Low
- ₹12
- 52 Week High
- ₹65
- Open Price₹40
- Previous Close₹40
- Volume85,422
- 50 DMA₹42.67
- 100 DMA₹41.44
- 200 DMA₹35.71
Investment Returns
- Over 1 Month -6.04%
- Over 3 Month -22.42%
- Over 6 Month + 40.1%
- Over 1 Year + 64.69%
Smart Investing Starts Here Start SIP with Shukra Pharmaceuticals for Steady Growth!
Shukra Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 59.6
- PEG Ratio
- 0.2
- Market Cap Cr
- 1,738
- P/B Ratio
- 20.2
- Average True Range
- 2.73
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.97
- RSI
- 46.51
- MFI
- 51.4
Shukra Pharmaceuticals Financials
Shukra Pharmaceuticals Technicals
EMA & SMA
Current Price
₹39.69
-0.4
(-1%)
- Bearish Moving Average 13
- Bullish Moving Average 3
- 20 Day
- ₹41.13
- 50 Day
- ₹42.67
- 100 Day
- ₹41.44
- 200 Day
- ₹35.71
Resistance and Support
40.97
- R3 44.74
- R2 43.78
- R1 41.93
- S1 39.12
- S2 38.16
- S3 36.31
Shukra Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-03-16 | Others | Inter-alia, to consider 1. To review the performance of Non-Independent Directors and the Board as a whole. 2. To Review the performance of the Chairman of the Company. 3. Other business matters. alia, 1. To consider in principle, the issue of equity shares of face value of Rs. 10/- each on a rights basis ("Rights Issue") to the shareholders of the Company. |
| 2026-02-04 | Quarterly Results | (Revised) alia, 1. To consider in principle, the issue of equity shares of face value of Rs. 10/- each on a rights basis ("Rights Issue") to the shareholders of the Company. |
| 2025-11-13 | Quarterly Results | |
| 2025-10-03 | Others | Inter-alia, to consider 1. To declare and fix relevant date for the Pproposed preferential issue. 2. fix day, date, time and venue for Extra-ordinary General meeting (EGM). 3. Other business matters. alia, 1. To consider in principle, the issue of equity shares of face value of Rs. 10/- each on a rights basis ("Rights Issue") to the shareholders of the Company. |
| 2025-08-13 | Quarterly Results |
Shukra Pharmaceuticals F&O
About Shukra Pharmaceuticals
- NSE Symbol
- SHUKRAPHAR
- BSE Symbol
- 524632
- Managing Director
- Mr. Dakshesh Rameshchandra Shah
- ISIN
- INE551C01044
Similar Stocks to Shukra Pharmaceuticals
Shukra Pharmaceuticals FAQs
Shukra Pharmaceuticals share price is ₹39 As on 13 March, 2026 | 16:04
The Market Cap of Shukra Pharmaceuticals is ₹1737.9 Cr As on 13 March, 2026 | 16:04
The P/E ratio of Shukra Pharmaceuticals is 59.6 As on 13 March, 2026 | 16:04
The PB ratio of Shukra Pharmaceuticals is 20.2 As on 13 March, 2026 | 16:04
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.